Appraising ascorbic acid as a chemoprevention agent for acute myeloid leukaemia using Mendelian Randomisation
Blood Cancer J
.
2024 Oct 18;14(1):183.
doi: 10.1038/s41408-024-01168-7.
Authors
Sina A Beer
1
,
Molly Went
2
,
Jessica M Hislop
2
,
Richard Houlston
2
,
Martin Kaiser
2
3
Affiliations
1
Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK. sina.beer@icr.ac.uk.
2
Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK.
3
The Royal Marsden Hospital NHS Foundation Trust, London, UK.
PMID:
39424823
PMCID:
PMC11489766
DOI:
10.1038/s41408-024-01168-7
No abstract available
Publication types
Letter
Grants and funding
C1298/A8362/Cancer Research UK (CRUK)
C1298/A8362/Cancer Research UK (CRUK)
C1298/A8362/Cancer Research UK (CRUK)
C1298/A8362/Cancer Research UK (CRUK)
C1298/A8362/Cancer Research UK (CRUK)